Genistein effects on stromal cells determines epithelial proliferation in endometrial co-cultures.

[1]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[2]  R. Simmen,et al.  PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. , 2010, Carcinogenesis.

[3]  L. Cubano,et al.  Individual and combined soy isoflavones exert differential effects on metastatic cancer progression , 2010, Clinical & Experimental Metastasis.

[4]  G. Colditz,et al.  Obesity and Cancer , 2010, The oncologist.

[5]  H. Zhang,et al.  Daidzein Effect on Hormone Refractory Prostate Cancer In Vitro and In Vivo Compared to Genistein and Soy Extract: Potentiation of Radiotherapy , 2010, Pharmaceutical Research.

[6]  Jun Wang,et al.  Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag rats , 2009, The Prostate.

[7]  M. Neves-e-Castro.  Association of Ovarian and Uterine Cancers With Postmenopausal Hormonal Treatments , 2008, Clinical obstetrics and gynecology.

[8]  Susan R Woskie,et al.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.

[9]  D. Kaufman,et al.  Effects of Tibolone Metabolites on Human Endometrial Cell Lines in Co-culture , 2008, Reproductive Sciences.

[10]  S. Zeisel,et al.  Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis and estrogenic outcomes in healthy, post‐menopausal women ‐ a Phase I clinical trial , 2007, Menopause.

[11]  H. Jarry,et al.  Effects of Chronic Genistein Treatment in Mammary Gland, Uterus, and Vagina , 2007, Environmental health perspectives.

[12]  Sanjeev Banerjee,et al.  Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model , 2007, International journal of cancer.

[13]  Sue Marty,et al.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. , 2006, Birth defects research. Part B, Developmental and reproductive toxicology.

[14]  S. Malaivijitnond,et al.  Genistein enhances N-nitrosomethylurea-induced rat mammary tumorigenesis. , 2006, Cancer letters.

[15]  A. Cassidy.  Factors affecting the bioavailability of soy isoflavones in humans. , 2006, Journal of AOAC International.

[16]  G. Vollmer,et al.  Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  Masakazu Toi,et al.  Clinical significance of estrogen receptor β in breast cancer , 2005, Cancer Chemotherapy and Pharmacology.

[18]  D. Kaufman,et al.  Expression of Exogenous Human Telomerase in Cultures of Endometrial Stromal Cells Does Not Alter Their Hormone Responsiveness1 , 2005, Biology of reproduction.

[19]  Masakazu Toi,et al.  Clinical significance of estrogen receptor beta in breast cancer. , 2005, Cancer chemotherapy and pharmacology.

[20]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[21]  P. Cooke,et al.  Role of stromal-epithelial interactions in hormonal responses. , 2004, Archives of histology and cytology.

[22]  F. Sarkar,et al.  Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. , 2004, Molecular cancer therapeutics.

[23]  A. Caldarelli,et al.  The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression , 2004, Molecular and Cellular Endocrinology.

[24]  E. Weiderpass,et al.  Childbearing at older age and endometrial cancer risk (Sweden) , 1999, Cancer Causes & Control.

[25]  R. Kaaks.  Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. , 2004, Novartis Foundation symposium.

[26]  K. Korach,et al.  Estrogen receptor knockout mice as a model for endocrine research. , 2004, ILAR journal.

[27]  A. Genazzani,et al.  Hormone replacement therapy and endometrial, ovarian and colorectal cancer. , 2003, Best practice & research. Clinical endocrinology & metabolism.

[28]  U. Jeschke,et al.  Immunohistochemical expression of steroid receptors and glycodelin A in isolated proliferative human endometrial glandular cells after stimulation with tamoxifen and phytoestrogens (genistein and daidzein). , 2003, Anticancer Research.

[29]  M. Schell,et al.  Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. , 2002, The American journal of clinical nutrition.

[30]  D. Kaufman,et al.  Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. , 2002, Cancer research.

[31]  J T Arnold,et al.  Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. , 2001, Human reproduction.

[32]  K. Korach,et al.  Postnatal Sex Reversal of the Ovaries in Mice Lacking Estrogen Receptors α and β , 1999 .

[33]  I Persson,et al.  Risk of endometrial cancer following estrogen replacement with and without progestins. , 1999, Journal of the National Cancer Institute.

[34]  K. Korach,et al.  Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. , 1999, Annales d'endocrinologie.

[35]  K. Korach,et al.  Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. , 1999, Science.

[36]  D. Lubahn,et al.  Mechanism of Estrogen Action: Lessons from the Estrogen Receptor-α Knockout Mouse , 1998 .

[37]  N. Weiss,et al.  Risk of Endometrial Cancer in Relation to Use of Low‐Dose, Unopposed Estrogens , 1998, Obstetrics and gynecology.

[38]  D. Lubahn,et al.  Mechanism of estrogen action: lessons from the estrogen receptor-alpha knockout mouse. , 1998, Biology of reproduction.

[39]  K. Korach,et al.  Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Thomas T. Y. Wang,et al.  Molecular effects of genistein on estrogen receptor mediated pathways. , 1996, Carcinogenesis.

[41]  G. Peterson.  Evaluation of the biochemical targets of genistein in tumor cells. , 1995, The Journal of nutrition.

[42]  C. la Vecchia,et al.  Family history and the risk of endometrial cancer , 1994, International journal of cancer.

[43]  R. Hochberg,et al.  A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. , 1990, Endocrinology.

[44]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[45]  M. Nishida,et al.  [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. , 1985, Nihon Sanka Fujinka Gakkai zasshi.

[46]  J. R. Evrard.  Protection against endometrial carcinoma by combination-product oral contraceptives. , 1982, JAMA.